hahahaha.... we are way too early for this discussion...
remember we don't even have a P1 data.....in my years of experience not only on ASX but also being part of various Pharmaceutical companies over last 10 plus years.....it all depends on multiple things.....
max valuation I have seen post P2 and a company in P3 with one single asset is approx. 10b..... it was for a gene therapy company fixing a very niche market.....
let's hope the data comes out to be exceptional .... and given what's it's trying to solve.... if there is ever a take over, it will be billions not 1 billion ..
but like I said .... too early, we have a lot of hurdles to go through .... minimum wait in my view is 3-4 years...
- Forums
- ASX - By Stock
- AGN
- Ann: Positive Preclinical Data for ARG-007 Neuroprotection in HIE
Ann: Positive Preclinical Data for ARG-007 Neuroprotection in HIE, page-87
Featured News
Add AGN (ASX) to my watchlist
(20min delay)
|
|||||
Last
72.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $88.42M |
Open | High | Low | Value | Volume |
72.0¢ | 72.0¢ | 72.0¢ | $25.84K | 35.89K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 71.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
72.0¢ | 9714 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.715 |
1 | 5632 | 0.710 |
5 | 18778 | 0.700 |
3 | 16703 | 0.695 |
1 | 1169 | 0.690 |
Price($) | Vol. | No. |
---|---|---|
0.720 | 9714 | 1 |
0.725 | 846 | 1 |
0.745 | 11122 | 1 |
0.750 | 8888 | 1 |
0.780 | 6813 | 2 |
Last trade - 10.00am 24/05/2024 (20 minute delay) ? |
Featured News
AGN (ASX) Chart |